GIP receptor antagonist (IC50 = 2.6µM). Inhibits GIP-stimulated insulin release from pancreatic beta cells in vitro. In ob/ob mice, blocks the effects of GIP on insulin release and plasma glucose levels. Also improves intraperitoneal glucose tolerance, insulin sensitivity, and glucose response to feeding in ob/ob mice.
Molekulargewicht:
4971.62
Formel:
C225H342N62O64S
Target-Kategorie:
IGF-1R
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten